 For Appointments
617-726-5184
Fax
617-726-3603
Office Address
Massachusetts General Hospital Cancer Center
Dept. of Radiation Oncology
55 Fruit Street
Boston, MA 02114
Clinical Interests
Pediatric Oncology, Proton Radiotherapy, Thoracic Oncology, Intensity Modulated Radiation Therapy
Education
MD Degree: Harvard Medical School, Boston, MA, 1998
Postdoctoral Training
Residency: Massachusetts General Hospital, Boston, MA
Board Certification
Radiation Oncology, 2003
Hospital Appointments
Assistant, Radiation Oncology
Massachusetts General Hospital
Academic Appointments
Assistant Professor, Radiation Oncology
Harvard Medical School
Research Interests
Image guided radiotherapy; Acute and late effects of radiation therapy; proton radiotherapy; Improving conformality of radiation treatment, Pediatric sarcomas and brain tumors; Imaging endpoints for radiation effects on normal tissue and tumor, Children’s Oncology Group, Pediatric Brain Tumor Consortium, Quality of Life in cancer survivors
My Publications
Link to PubMed Database
Selected Publications
Gibbs IC, Tuamokumo N, Yock, TI, Role of Radiation Therapy in Pediatric Cancer. Hematology/Oncology Clinics of North America, Radiation Medicine Update for the Practicing Oncologist, Part II, 2006, 20(2)455-470.
Yock TI, Schneider RJ, Friedmann A, Adams J, Fullerton B, Tarbell NJ. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photon radiation. Int J Radiation Oncology Biol Phys 63(4)1161-1168, 2005.
Yock TI, Tarbell NJ. Proton beam therapy for treatment in pediatric brain tumors, Nature Clinical Practice Oncology 2004; 1(2):97-103.
Yock TI, Taghian AG, Kachnic LA, Coen JC, Assay SI, Powell SN, The Effect of Delaying Radiation Therapy for Systemic Chemotherapy on Local-Regional Control in Breast Cancer. Breast Cancer Research and Treatment; 84(2) 161-17, 2004.
Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ. Local control in pelvic Ewing's sarcoma: analysis from INT-0091: A report from the Children's Oncology Group. Journal of Clinical Oncology 24(24)3838-3843.
| 
